Diabetes is a serious, long-term (or chronic) disease that occurs when a person’s blood sugar levels are high because their body cannot produce enough insulin, or does not produce enough insulin or that it cannot effectively use the insulin it produces. According to the literature, this disease has several causes, but certain types of diabetes such as type 2 diabetes are most closely linked to a metabolic disorder due to abdominal obesity. Thus, the number of individuals with type 2 diabetes is increasing. It is with this in mind that we work to improve human health. The aim of this study is to design new derivatives of 1,3,4-thiadiazole with improved antidiabetic activity by the mathematical model of multiple linear regression (MLR) established previously. The analysis of the effect on the substituents influencing the antidiabetic activity, fourteen (14) new molecules coded CDTH were generated and presenting values of the potential of inhibitory concentration higher than that of the base compound (pIC50 = 2.526). But thirteen (13) of these new compounds belong to the domain of applicability of the MLR model established previously. In addition, the thermodynamic quantities of formation formed at 298K have been calculated. Lipinski’s rule and pharmacokinetic properties proved that five (5) (TH4, TH9, TH10, TH13 and TH14) new molecules can be used as diabetes medicine.
References
[1]
Wild, S., Roglic, G., Green, A., Sicree, R. and Hilary, K. (2004) Global Prevalence of Diabetes: Estimates for the Year 2000 and Projection for 2030. Diabetes Care, 27, 1047-1053. https://doi.org/10.2337/diacare.27.5.1047
[2]
Rodier, M. (2001) Définition et classification du diabète. Imageriefonctionnelle et métabolique, Médecine Nucléaire, 25, 91-93.
[3]
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A., Ogurtsova, K., Shaw, J., Bright, D., Williams, R. and IDF Diabetes Atlas Committee (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
[4]
Tripathi, B. and Srivastava, A. (2006) Diabetes Mellitus: Complications and Therapeutics. Medical Science Monitor, 12, 130-147.
[5]
Kittur, B., Sastry, B., Thakur, J.S.D. and Pattan, S. (2011) Synthesis and Biological Evaluation of Some Novel 1, 3, 4-Thiadiaazoles for Antidiabetic Activity. Indian Journal of Chemistry, 50, 615-618.
[6]
Kempgowda, S., Prakash, G.D. and Tamiz, M. (2011) Thiadiazoles: Progress Report on Biological Activities. Der Pharma Chemica, 3, 330-341.
[7]
Kamal, M., Shakya, A. and Talha, J. (2011) 1, 3, 4-Thiadiazoles as Antimicrobial Agent: A Review. International Journal of Biomedical Research, 2, 41-61.
[8]
Singh, A., Mishra, G. and Jyoti, K. (2011) Review on Biological Activities of 1, 3, 4-Thiadiazole Derivatives. Journal of Applied Pharmaceutical Science, 1, 44-49.
[9]
Jalhan, S., Anil, J., Avneet, G. and Hemraj, (2012) Synthesis, Biological Activities and Chemistry of Thiadiazole Derivatives and Schiff Bases. Asian Journal of Pharmaceutical and Clinical Research, 5, 199-208.
[10]
Siddiqui, N., Ahuja, P., Ahsan, W. and Alam, M. (2009) Thiadiazoles: Progress Report on Biological Activities. Journal of Chemical and Pharmaceutical Research, 1, 19-30.
[11]
Hemal, B., Dipansu, S., Biren, S., Dixit, C. and Mandev, P. (2011) Biological Profile of Thiadiazole. PharmacologyOnLine, 1, 528-543.
[12]
Roy, K., Kar, S. and Das, R.N. (2015) Statistical Methods in QSAR/QSPR. In: Roy, K., Kar, S. and Das, R.N., Eds., A Primer on QSAR/QSPR Modeling, Springer, Cham, 37-59. https://doi.org/10.1007/978-3-319-17281-1_2
[13]
Oprea, T.I. (2005) Chemoinformatics in Drug Discovery. WILEY-VCH, Weinheim. https://doi.org/10.1002/3527603743
[14]
Rekka, E.A. and Kourounakis, P.N. (2008) Chemistry and Molecular Aspects of Drug Design and Action. CRC Press, Boca Raton. https://doi.org/10.1201/9781420008272
[15]
Dou, C., Koné, M.R., Dembélé, G.S., Soro, D., Konaté, F. and Ziao, N. (2022) Development of a Predictive Model of the Antidiabetic Activity of a Thiadiazole Molecule Series by Density Functional Theory Method. Journal of Materials Physics and Chemistry, 10, 49-58.
[16]
Shuker, S., Hajduk, P., Meadows, R. and Fesik, S. (1996) Discovering High-Affinity Ligands for Proteins: SAR by NMR. Science, 274, 1531-1534. https://doi.org/10.1126/science.274.5292.1531
[17]
Kuo, L. (2011) Fragment-Based Drug Design: Tools, Practical Approches and Examples. Academic Press, London.
[18]
Konate, F., Diarrrassouba, F., Soro, D., Dembele, G., Koné, M.R., Konaté, B. and Ziao, N. (2021) Design of New Dihydrothiophenone Derivatives with Improved Anti-Malaria Activity. Mediterranean Journal of Chemistry, 11, 290-298.
[19]
Dembele, G., Tuo, N., Konaté, F., Soro, D., Konaté, B. and Ziao, N. (2022) Quantitative Structure Activity Relationship (QSAR) Study of Series of Molecules Derived from Thiazoline and Thiazine Multithioether against Antitumor Activity (A-549). International Journal of Chemical and Lifesciences, 11, 2426-2435.
[20]
Dembélé, G.S., Koné, M.G.R., Ouattara, B., Konate, F., Soro, D. and Ziao, N. (2022) Quantitative Structure-Activity Relationship (QSAR) Study of a Series of Chalcone Derivatives Inhibiting Plasmodium Falciparum 3D7. American Journal of Physical Chemistry, 11, 1-13. https://doi.org/10.11648/j.ajpc.20221101.11
[21]
Dembélé, G., Koné, M.G.R., Konate, F., Soro, D. and Ziao, N. (2022) Quantitative Structure-Activity Relationship Study of a Benzimidazole-Derived Series Inhibiting Mycobacterium tuberculosis H37Rv. Computational Chemistry, 10, 71-96. https://doi.org/10.4236/cc.2022.102004
Chase, M.W. (1985) JANAF Thermochemical Tables. 3rd Edition, American Institute of Physics, New York.
[24]
Lipinski, C.A., Lombardo, F., Dominy, B. and Feeney, P. (1997) Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Advanced Drug Delivery Reviews, 6, 3-25. https://doi.org/10.1016/S0169-409X(96)00423-1
[25]
(2021) The Metabolism of a Drug. http://udsmed.u-strasbg.fr/pharmaco/pdf/DCEM1_Pharmacologie_chapitre_5_Metabolisme_des_medic.pdf
[26]
Lee, S., Chang, G., Lee, I., Chung, J., Sung, K. and No, K. (2021) PreADMET. https://preadmet.bmdrc.kr/
